Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG).
J Cancer Res Clin Oncol
; 146(7): 1829-1845, 2020 Jul.
Article
em En
| MEDLINE
| ID: mdl-32410064
ABSTRACT
PURPOSE:
The outcome of RCC has improved considerably in the last few years, and the treatment options have increased. LACOG-GU and LARCG held a consensus meeting to develop guidelines to support the clinical decisions of physicians and other health professionals involved in the care of RCC patients.METHODS:
Eighty questions addressing relevant advanced RCC treatments were previously formulated by a panel of experts. The voting panel comprised 26 specialists from the LACOG-GU/LARCG. Consensus was determined as 75% agreement. For questions with less than 75% agreement, a new discussion was held, and consensus was determined by the majority of votes after the second voting session.RESULTS:
The recommendations were based on the highest level of scientific evidence or by the opinion of the RCC experts when no relevant research data were available.CONCLUSION:
This manuscript provides guidance for advanced RCC treatment according to the LACOG-GU/LARCG expert recommendations.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Carcinoma de Células Renais
/
Neoplasias Renais
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article